EGEIRO PHARMA
- 0684.906.013
- BE0684906013
- Avenue Jean Mermoz 32, 6041 Charleroi
- See the 3 companies at this address
- 22 November 2017
Profile
Official information from the CBE (FPS Economy).
EGEIRO PHARMA is a Belgian company (Société anonyme) whose registered office is established at 6041 Charleroi. Its main activity falls under “Fabrication d’autres produits chimiques inorganiques de base” (NACE 20130).
- Legal form
- Société anonyme
- Legal situation
- Ouverture de faillite
- Date of incorporation
- 22 November 2017
- Main activity (NACE)
- 20130Fabrication d’autres produits chimiques inorganiques de base
An activity that is, on the face of it, not covered by anti-money-laundering law. Learn more
Secondary activities
1 additional NACE code declared.
Your risk analysis on this company
AML Company ran EGEIRO PHARMA through your due diligence questionnaire. Here are the first findings.
What is the geographic exposure of the client and of its transactions?
Belgium only· Registered office published in the register
What is the company's solvency and lifecycle status?
Declared bankrupt· Legal situation published in the register
Sanctions screening, politically exposed persons, ultimate beneficial owners, source of funds: AML Company runs them, documents them and keeps the proof in your file.
Run the full analysisThis preview is not a due diligence measure: it pre-qualifies questions from public data. Identifying the client and its ultimate beneficial owners requires documents collected and verified.
Establishments
2 active establishment units declared with the CBE.
Finances & financial health
Annual accounts filed with the Central Balance Sheet Office (CBSO, National Bank of Belgium) and an aggregate health score (Altman Z″ model, completed with qualitative factors).
Equity & result
| Financial year | Equity | Result | Turnover / gross margin | Headcount (FTE) |
|---|---|---|---|---|
| 2022 | €7,521,135 | -€2,315,628 | €94,037turnover | 11,9 |
| 2021 | €9,647,627 | -€1,340,850 | €12,348turnover | 7,7 |
| 2020 | – | – | - | – |
| 2019 | – | – | - | – |
Financial ratios
Solvency, liquidity and profitability, computed year by year from the filed annual accounts.
Equity / balance sheet total
Current assets / debts due within one year
Result for the year / turnover
Operating result / turnover
Debts due after one year / balance sheet total
Result for the year / equity
Balance sheet structure
| Ratio | 2022 | 2021 | 2020 | Trend |
|---|---|---|---|---|
| Solvency | 79,2% 5,1% | 84,2% | - | |
| Liquidity | 3,31 x 3,65 | 6,96 x | - | |
| Net margin | -2.462,5% 8.396,3% | -10.858,8% | - | |
| Operating margin | -2.952,8% 11.048,7% | -14.001,5% | - | |
| Long-term debt | 9,4% 1,5% | 7,9% | - | |
| Return on equity | -30,8% 16,9% | -13,9% | - |
Ratios computed by AML Company from the items filed in the balance sheet and the income statement. They are not filed figures as such: the underlying amounts appear in the key figures above.
Filing history (5)▾
Source: CBSO (NBB) filings, Belgian chart-of-accounts headings 9904 (result), 10/15 (equity), 9900 (gross margin), 9087 (workforce in FTE). Data available for filings from 2022 onwards.
The grade, the score out of 100, the Altman Z″ zone and the list of public alerts are for members only.
Notices in the Belgian Official Gazette
Official acts and notices: incorporation, changes to the articles, appointments, dissolutions.
- STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, �)20 December 2024
- CAPITAL, ACTIONS17 December 2024
- DEMISSIONS, NOMINATIONS13 December 2024
- DEMISSIONS, NOMINATIONS22 November 2024
- DENOMINATION - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS12 November 2024
Source: Belgian Official Gazette (FPS Justice). The links open the official PDFs.
What the EGEIRO PHARMA record does not say
Two readings of the register the raw data does not give: anti-money-laundering scope, and whether the filing deadline was met.
Is EGEIRO PHARMA subject to anti-money-laundering obligations in Belgium?
Did EGEIRO PHARMA file its annual accounts on time?
Company timeline
Every dated event in the company's life, from filed accounts to notices published in the Belgian Official Gazette, in a single thread.
10 AI-analysed dimensions are not shown.
- 2024
- 12 November 2024Company name · Capital · Shares · Appointments · ResignationsView the notice24442799
- 2023
- 6 June 2023Annual accounts filed·Financial year ended 31 December 2022 · Model m02-fFiled accounts2023-00117479
Registry record since 7 September 2026
The KBO publishes its changes as a monthly delta and never restates the past: our record starts on that date, not at the company's incorporation. No change recorded since that date. A missing row says nothing about the company, only about how far back our record goes.
AI extraction of strategic AML data
The official notices in the Belgian Official Gazette are analysed by our AI engine to extract automatically the information that matters for your due diligence and your AML duties.
- Legal life
- Restructuring
- Capital
- Legal form
- Incorporation
- Directors
- Beneficial owners
- Registered office
- Company name
- Notarial deeds
Similar companies
Same business sector and geographic area.
Covestro
SOLVAY
DE CRAENE
SOLVAY CHIMIE
DEQUACHIM
SILMACO
OXYPLAST BELGIUM
DEQUENNE CHIMIE
RdH Consulting
Step it up
Full analysis unlocked.
Create an account to unlock the detailed analysis: health score, full history, alerts and PDF exports.